← Market Map Market Map · Infrastructure & Cross-Cutting

Remote Monitoring and Devices

The pediatric RPM market bifurcates: a consumer layer with broad adoption but limited reimbursement, and a clinical RPM track where FDA clearance and hospital partnerships unlock payer reimbursement.

Last updated: April 2026 · Substantially upgraded — full rewrite

Key Companies

Company Product Focus Stage
Owlet (BabySat) FDA-cleared prescription infant pulse ox Post-NICU clinical RPM; CHD, chronic lung disease Public (NYSE: OWLT)
Locus Health RPM + telehealth platform Pediatric post-discharge; NICU bridge-to-home Growth; hospital-anchored
Owlet (Dream Sock) Consumer infant monitor Consumer sleep/wellness tracking Consumer (separate from BabySat)
Kinsa Smart thermometer Illness monitoring + surveillance Growth
Nanit Baby monitor Sleep and development tracking Consumer
Sibel Health Wireless neonatal skin sensor NICU bedside monitoring Startup
Dimer Health AI-powered post-discharge monitoring Continuous risk scoring + proactive outreach Early-growth

Market Dynamics

  • Clinical RPM is the high-value lane. Owlet BabySat's FDA clearance and Locus Health hospital partnerships represent the template — hardware + platform + hospital workflow integration + payer reimbursement. Consumer wearables are lower-margin and payer-uncovered.
  • ~500,000 annual NICU-to-home infants are the core addressable population for clinical infant RPM.
  • CMC post-discharge readmission data makes the ROI case: 16–53% thirty-day readmission rates; 82% classified as potentially preventable. An RPM + telehealth + care navigation bundle is the intervention architecture with the strongest evidence.
  • Consumer adoption ahead of reimbursement. Parents are actively adopting wearables but coverage remains narrow.
  • Adult-first post-discharge RPM has a proven template. Dimer Health's 67% readmission reduction in adults — if replicated in CMC pediatrics — would represent hundreds of millions in avoidable hospitalization costs. No pediatric-native post-discharge AI monitoring platform exists at scale.
  • Off-label equipment problem in pediatric home care. Most home respiratory DME is designed for adults. Sunset Healthcare's Brighter Pediatrics line (launched November 2024) is one of the few purpose-built pediatric respiratory product lines for the home care setting.

Notable Recent Activity

  • Owlet + Locus Health partnership (November 2025): BabySat SpO2 + HR data integrated into Locus Health RPM clinical workflows; ~500,000 addressable infants; Owlet reported first operating profit Q3 2025, 33% FY2025 revenue growth
  • Vanderbilt NICU Bridge to Home (launched 2024): Locus Health app on pre-loaded iPads; daily weight/feeding data; weekly telehealth; 43 patients through Aug 2025
  • Dimer Health expanding AI-powered post-discharge monitoring platform (NY, NJ, FL); 67% readmission reduction in adult cohort; architecture directly applicable to pediatric complex discharge
  • Sunset Healthcare Brighter Pediatrics line launched November 2024: pediatric NIV/CPAP masks, ventilator circuits, Microflow Microdial Flowmeter for precise infant O2 delivery; B2B to DME providers